Guangzhou Jeep Biotechnology JEEP: Lab Test Results
Independent Certificates of Analysis aggregated from public lab results. Not affiliated with or paid by Guangzhou Jeep Biotechnology JEEP.
59
CoAs on file
98.99%
Avg reported purity
6
Compounds tested
Sep 24, 2026
Latest test
Results by compound
| Compound | CoAs | Avg purity | Latest |
|---|---|---|---|
| Retatrutide | 28 | 99.54% | Sep 24, 2026 |
| Tirzepatide | 16 | 99.79% | Aug 4, 2026 |
| GHK-Cu | 5 | 99.83% | Jul 13, 2026 |
| Tesamorelin | 4 | 94.08% | Aug 9, 2026 |
| CJC-1295 No DAC | 3 | 94.59% | Feb 20, 2026 |
| Ipamorelin | 3 | 99.68% | Feb 20, 2026 |
Recent CoAs
| Compound | Batch | Purity | Lab | Tested | |
|---|---|---|---|---|---|
| Retatrutide | JP20260015 | 99.9% | Lab E | Sep 24, 2026 | verify |
| Retatrutide | JP20260016 | 99.9% | Lab E | Sep 23, 2026 | verify |
| Retatrutide | Jp20260024 | 99.9% | Lab E | Sep 18, 2026 | verify |
| Retatrutide | JP20260017 | n/a | Lab G | Sep 16, 2026 | verify |
| Retatrutide | JP20260016 | 99.9% | Lab E | Sep 15, 2026 | verify |
| Retatrutide | JP20260015 | 99.9% | Lab E | Aug 26, 2026 | verify |
| Retatrutide | JP20260002 | 99.9% | Lab E | Aug 12, 2026 | verify |
| Retatrutide | Jp20260017 | 93.8% | Lab E | Aug 12, 2026 | verify |
| Tesamorelin | LOT:TS10BT MFG:06/01/2026 EXP:06/01/2028 | 99.7% | Lab G | Aug 9, 2026 | verify |
| Retatrutide | JP20260017 | 99.9% | Lab E | Aug 5, 2026 | verify |
| Tirzepatide | LOT:TR20BLT MFG:06/01/2026 EXP:06/01/2028 | 99.9% | Lab E | Aug 4, 2026 | verify |
| Retatrutide | LOT:RT10PT MFG:06/01/2026 EXP:06/01/2028 | 99.3% | Lab E | Aug 4, 2026 | verify |
| Retatrutide | JP20260017 | n/a | Lab G | Aug 3, 2026 | verify |
| Retatrutide | JP20260017 | 99.7% | Lab G | Aug 2, 2026 | verify |
| Tirzepatide | JP20250826 | 99.9% | Lab E | Jul 20, 2026 | verify |
| Retatrutide | Jp20260016 | 98.6% | Lab E | Jul 20, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Jul 17, 2026 | verify |
| GHK-Cu | n/a | 99.8% | Lab E | Jul 13, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Jul 13, 2026 | verify |
| Tesamorelin | n/a | 94.8% | Lab E | Jul 13, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Jul 13, 2026 | verify |
| Retatrutide | JP20250821 | 99.9% | Lab E | Jun 16, 2026 | verify |
| Retatrutide | JP20250827 | 99.9% | Lab E | Jun 15, 2026 | verify |
| Retatrutide | JP20250616 | 99.9% | Lab E | May 20, 2026 | verify |
| Tirzepatide | JP20250617 | 99.9% | Lab E | May 20, 2026 | verify |
Showing 25 most recent of 59. Search the full database on the CoA page.
Embed this badge
Sell or represent Guangzhou Jeep Biotechnology JEEP? Link your customers to this page with the badge below. Free, no signup. The badge and counts update as new lab results land.
<a href="https://ascendpeptide.org/coa/vendor/guangzhou-jeep-biotechnology-jeep/" rel="noopener"> <img src="https://ascendpeptide.org/coa/badge/guangzhou-jeep-biotechnology-jeep.svg" alt="Guangzhou Jeep Biotechnology JEEP: lab tested, 59 CoAs on file at ASCEND Peptide" width="230" height="54"> </a>
Data comes from publicly posted third-party lab certificates (Janoshik, MZ Biolabs, and others) and community submissions. Purity figures are as reported by the testing lab for the specific batch tested; they are not a guarantee of any other batch. For research and informational purposes only.